These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 37092892)
1. Synthesis and Evaluation of a Self-Adjuvanting Pseudomonal Vaccine Based on Major Outer Membrane Porin OprF Epitopes Formulated with Low-Toxicity QS-21-Containing Liposomes. Thanvi R; Nada S; Dissanayake R; Vartak A; Sebilleau CO; Alom NE; Prestwich EG; Wall KA; Sucheck SJ Bioconjug Chem; 2023 May; 34(5):893-910. PubMed ID: 37092892 [No Abstract] [Full Text] [Related]
2. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine. Zhou S; Song Y; Nilam A; Luo Y; Huang WC; Long MD; Lovell JF J Control Release; 2024 May; 369():687-695. PubMed ID: 38575073 [TBL] [Abstract][Full Text] [Related]
3. Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii. Bahey-El-Din M; Mohamed SA; Sheweita SA; Haroun M; Zaghloul TI Int J Med Microbiol; 2020 Apr; 310(3):151415. PubMed ID: 32156509 [TBL] [Abstract][Full Text] [Related]
4. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053 [TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers. Westritschnig K; Hochreiter R; Wallner G; Firbas C; Schwameis M; Jilma B Hum Vaccin Immunother; 2014; 10(1):170-83. PubMed ID: 24064511 [TBL] [Abstract][Full Text] [Related]
6. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid. Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217 [TBL] [Abstract][Full Text] [Related]
7. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013. Genito CJ; Beck Z; Phares TW; Kalle F; Limbach KJ; Stefaniak ME; Patterson NB; Bergmann-Leitner ES; Waters NC; Matyas GR; Alving CR; Dutta S Vaccine; 2017 Jul; 35(31):3865-3874. PubMed ID: 28596090 [TBL] [Abstract][Full Text] [Related]
8. Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine. O'Donnell JS; Isaacs A; Jakob V; Lebas C; Barnes JB; Reading PC; Young PR; Watterson D; Dubois PM; Collin N; Chappell KJ Front Immunol; 2022; 13():976968. PubMed ID: 36119058 [TBL] [Abstract][Full Text] [Related]
9. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014 [TBL] [Abstract][Full Text] [Related]
10. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines. Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676 [TBL] [Abstract][Full Text] [Related]
11. Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review. Lacaille-Dubois MA Phytomedicine; 2019 Jul; 60():152905. PubMed ID: 31182297 [TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701 [TBL] [Abstract][Full Text] [Related]
13. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426 [TBL] [Abstract][Full Text] [Related]
15. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes. Brunner L; Barnier-Quer C; Collin N Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186 [TBL] [Abstract][Full Text] [Related]
16. Designing Adjuvant Formulations to Promote Immunogenicity and Protective Efficacy of Techawiwattanaboon T; Courant T; Brunner L; Sathean-Anan-Kun S; Krangvichian P; Iadsee N; Nakornpakdee Y; Sangjun N; Komanee P; Collin N; Ruxrungtham K; Patarakul K Front Cell Infect Microbiol; 2022; 12():918629. PubMed ID: 35782116 [TBL] [Abstract][Full Text] [Related]
17. Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate. Beck Z; Matyas GR; Alving CR Biochim Biophys Acta; 2015 Mar; 1848(3):775-80. PubMed ID: 25511587 [TBL] [Abstract][Full Text] [Related]
18. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Alipour M; Halwani M; Omri A; Suntres ZE Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881 [TBL] [Abstract][Full Text] [Related]
20. Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice. Shaikh MOF; Schaefers MM; Merakou C; DiBlasi M; Bonney S; Liao T; Zurakowski D; Kehl M; Tabor DE; DiGiandomenico A; Priebe GP Infect Immun; 2022 Oct; 90(10):e0020322. PubMed ID: 36069593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]